Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tiespectus
- Development stage
- Phase 3
- Lead developer
- Merck
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravitreal
01
Overview
Tiespectus (EYE201) is an investigational drug developed by Eyebiotech for ophthalmic indications. It is currently in Phase 1/2 clinical trials for the treatment of macular edema following branch retinal vein occlusion (BRVO), diabetic macular edema (DME), and neovascular age-related macular degeneration (NVAMD). The drug is administered via intravitreal injection. While the precise mechanism of action and molecular modality have not been publicly disclosed as of June 2025, Tiespectus represents a novel approach to treating retinal vascular diseases and related eye conditions[1][4][5].
- Brand names
- tiespectus
- Other names
- EYE201EYE-201EYE 201tiespectus
02
Targets
Beyond the preview
Go deeper on tiespectus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tiespectus.